Documentos relacionados

1. Antibodies to mutated citrullinated vimentin in patients with chronic hepatitis C virus genotype IV infection-related arthropathy.
2. Predicting factors for disappearance of anti-mutated citrullinated vimentin antibodies in sera of patients with rheumatoid arthritis.
3. Antibodies against a mutated citrullinated vimentin in patients with rheumatoid arthritis.
4. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
5. Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis.
6. Clinical Significance of Anti-Modified Citrullinated Vimentin Antibodies in Palindromic Rheumatism.
7. Anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis; diagnostic utility and association with deformities and disease activity.
8. Estudio de un neo-epítope para detección de anticuerposantitransglutaminasa en enfermedad celíaca
9. Anti-protein arginine deiminase antibodies are distinctly associated with joint and lung involvement in rheumatoid arthritis.
10. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].